Loading clinical trials...

The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal. | Clinical Trials | Clareo Health

COMPLETEDPHASE4

The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.

The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal in Children With Type 1 Diabetes Mellitus- Randomized Study.

NCT04124302•Medical University of Warsaw

View on ClinicalTrials.gov

Summary

The aim of the study is to compare the impact of two different insulin dose calculation on postprandial glycemia after mixed meal in children with type 1 diabetes mellitus.

Eligibility

Age

10 - 18 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•duration of type 1 diabetes longer than 12 months
•insulin pump therapy longer than 3 months
•treated by the same type of insulin longer than 3 months
•written informed consent by patients and parents

Exclusion Criteria

•celiac disease
•diabetes related complications (e.g. nephropathy)
•any disease judged by the investigator to affect the trial
•withdrawal of consent to participate in the study

Locations (1)

Warsaw Medical University

Warsaw, Poland

Key Dates

Start Date

October 1, 2019

Primary Completion Date

March 27, 2024

Completion Date

December 31, 2024

Last Updated

November 18, 2025

Enrollment

ACTUAL participants

Conditions

Diabetes Mellitus, Type 1

Interventions

Insulin Glulisine

DRUG

Insulin Aspart

DRUG

Insulin Lispro

DRUG

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

NCT04786262

Diabetes Mellitus, Type 1Impaired Hypoglycemic Awareness+1 more

View study

RECRUITINGNA

Fasted Exercise Training in Type 1 Diabetes (FED-T1D)

NCT06748963

Diabetes Mellitus, Type 1

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 18, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.

Inclusion Criteria

Exclusion Criteria

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

Fasted Exercise Training in Type 1 Diabetes (FED-T1D)

Closed Loop and Education for Hypoglycemia Awareness Restoration

A Research Study of a New Medicine NNC0363-1063 in Participants With Type 1 Diabetes

Achieving Health in Emerging Adults With Diabetes (AHEAD) Program: A Clinical Trial Designed to Understand if Participation in a Clinical Program Developed Specifically to Support Emerging Adults With Type 1 Diabetes Leads to Improved Diabetes Outcomes.

Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes